The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits.

The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits. Abstract Text:

P P Carbone,

The acceptance of ACT has been very rapid since 1974 although earlier studies by Nissen-Meyer and the NSABP in the 1960's originally suggested the effectiveness of modest short-term chemotherapy [16, 17]. The current practice is to administer combination chemotherapy for at least 6 months in all node-positive women. The survival benefits are clearly established only for women who are premenopausal and who have fewer than three positive nodes. Trials in other groups of patients are highly suggestive but have lacked some or all of the rigorous standards of the randomized clinical trial. The reasons for this widespread acceptance of ACT are not clear, but both patients and physicians are able to appreciate the concepts and bear the costs in terms of money as well as toxicity. The risks of ACT are mainly short term and reversible. Long-term consequences are not so readily apparent as yet. The benefits of improved survival will only be appreciated as more time passes, either through the long-term analyses of the current trials or the overwhelming success of a new strategy. Then all the past arguments about one therapy or another will become irrelevant. At that point this new miracle treatment will be so good that none will ask whether CMF is better than surgery alone. In essence, the old standard has become the control.

The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits. Publishing Authors By Initials

PP Carbone,

For similar organic chemicals: hydrocarbons: hydrocarbons, cyclic: hydrocarbons, aromatic: benzene derivatives: benzylidene compounds: stilbenes: tamoxifen research abstracts see: organic chemicals: hydrocarbons: hydrocarbons, cyclic: hydrocarbons, aromatic: benzene derivatives: benzylidene compounds: stilbenes: tamoxifen research

PUBMED ID PMID:

MEDLINE DATE:

The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 96

Page Numbers: 218-23

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1984

The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits. Keywords Mesh Terms:

KEYWORDS: Tamoxifen

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits. Information

Substance Name: Tamoxifen

Registry Number: 10540-29-1

Grant and Affiliation Information for The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits.

AFFILIATION:

Country: GERMANY, WEST

AGENCY: United States NCI

GRANT: CA-21115

ACRONYM: CA

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits Related Publications

• Algorithm to estimate the Hurst exponent of high-dimensional fractals.
• Breast cancer: changing strategy for treatment.
• Calcium channels in chromaffin cells: focus on L and T types.
• Can distance education prepare future public health nutritionists? A case study.
• Chronic hypoxia up-regulates alpha1H T-type channels and low-threshold catecholamine secretion in rat chromaffin cells.
• Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters.
• Dendritic cell-induced memory T cell activation in nonlymphoid tissues.
• Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.
• Fast exocytosis mediated by T- and L-type channels in chromaffin cells: distinct voltage-dependence but similar Ca2+ -dependence.
• Fatal stroke in a young cocaine drug addict: chemical hair analysis and cervical artery examination twenty months after death.
• Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
• Hypoalbuminemic and hypocholesterolemic effect of L-asparaginase (NSC-109,229) treatment in man--a preliminary report.
• Immune Activation and Increased Prevalence of Thrombosis in HIV Infection.
• Immunocell-array for molecular dissection of multiple signaling pathways in mammalian cells.
• Intraortic negative pressure suction during glue application.
• Is matching innate?
• L-type calcium channels in adrenal chromaffin cells: role in pace-making and secretion.
• METHYLTESTOSTERONE, RELATED STEROIDS, AND LIVER FUNCTION.
• Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.
• Ovarian endomyometrioma with atypias: description of a case.
• Phase I study of Paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer.
• Preliminary studies with dibromomannitol (NSC-94100) in patients with chronic myelogenous leukemia.
• Proteomics analysis in lung cancer: challenges and opportunities.
• Some observations of the behavior of amylase in relation to acute renal insufficiency.
• Spoken word frequency counts based on 1.6 million words in American English.
• The SV40 Large T Antigen-p53 Complexes Bind and Activate the Insulin-like Growth Factor-I Promoter Stimulating Cell Growth.
• The present dilemma of adjuvant chemotherapy: acceptance and risks versus benefits.
• Two-step aortic cross-clamping technique for acute type-a aortic dissection in octogenarians.
• [Chronic angioedema and blastocystis hominis infection]
• [Not Available.]